Idiopathic Pulmonary Fibrosis Market size is estimated to reach $4.7 billion by 2027, growing at a CAGR of 7.2% during the forecast period 2022-2027. Idiopathic pulmonary fibrosis (IPF) is a severe incessant ailment that influences the tissue surrounding...

Global Idiopathic Pulmonary Fibrosis (IPF) Market, By Medicine Type (Nintedanib, Pirfenidone, Other), By Mode of Application (Antifibrotic Agents, Tyrosine Kinase Inhibitors, Other), By End User (Hospitals and Clinics, Other) and opportunities and forecas...